Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics.

Schoch, Sarah; Gajewski, Sabine; Rothfuß, Jana; Hartwig, Andrea; Köberle, Beate

Schoch, Sarah; Gajewski, Sabine; Rothfuß, Jana; Hartwig, Andrea; Köberle, Beate.

Affiliation

Schoch S; Department of Food Chemistry and Toxicology, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.
Gajewski S; Department of Laboratory Medicine, Lund University, Scheelevägen 2, 22381 Lund, Sweden.
Rothfuß J; Department of Food Chemistry and Toxicology, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.
Hartwig A; Department of Food Chemistry and Toxicology, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.
Köberle B; Department of Food Chemistry and Toxicology, Karlsruhe Institute of Technology, Adenauerring 20a, 76131 Karlsruhe, Germany.

Int J Mol Sci ; 21(18)2020 Sep 21.

Article de En | MEDLINE | ID: mdl-32967255

Sujet(s)
Mots clés

DNA damage response; cisplatin analogues; gene expression profiling; tumor cells

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carboplatine / Cisplatine / Oxaliplatine / Tumeurs Limites: Humans Langue: En Journal: Int J Mol Sci Année: 2020 Type de document: Article Pays d'affiliation: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google